Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Glycoprotein – e.g. – mucins – proteoglycans – etc.
Reexamination Certificate
2006-11-14
2006-11-14
Carlson, Karen Cochrane (Department: 1653)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Glycoprotein, e.g., mucins, proteoglycans, etc.
C530S350000, C530S391300, C435S449000, C424S192100
Reexamination Certificate
active
07135556
ABSTRACT:
We claim an isolated polypeptide having ability of binding with cholesterol. Said polypeptide is useful for investigating regulation of intestinal cholesterol absorption and cholesterol levels. Also, we claim a composition comprising said polypeptide bound to cholesterol or ezetimibe and a fusion protein comprising the polypeptide thereof.
REFERENCES:
patent: 5306817 (1994-04-01), Thiruvengadam et al.
patent: 5561227 (1996-10-01), Thiruvengadam et al.
patent: 5618707 (1997-04-01), Homann et al.
patent: 5624920 (1997-04-01), McKittrick et al.
patent: 5627176 (1997-05-01), Kirkup et al.
patent: 5631365 (1997-05-01), Rosenblum et al.
patent: 5633246 (1997-05-01), McKittrick et al.
patent: 5656624 (1997-08-01), Vaccaro et al.
patent: 5661145 (1997-08-01), Davis
patent: 5688785 (1997-11-01), Vaccaro
patent: 5688787 (1997-11-01), Burnett et al.
patent: 5688990 (1997-11-01), Shankar
patent: 5698548 (1997-12-01), Dugar et al.
patent: 5728827 (1998-03-01), Thiruvengadam et al.
patent: 5739321 (1998-04-01), Wu et al.
patent: 5744467 (1998-04-01), McKittrick et al.
patent: 5756470 (1998-05-01), Yumibe et al.
patent: 5767115 (1998-06-01), Rosenblum et al.
patent: 5846966 (1998-12-01), Rosenblum et al.
patent: 5856473 (1999-01-01), Shankar
patent: 5886171 (1999-03-01), Wu et al.
patent: 5919672 (1999-07-01), Homann et al.
patent: 6093812 (2000-07-01), Thiruvengadam et al.
patent: 6096883 (2000-08-01), Wu et al.
patent: 6133001 (2000-10-01), Homann et al.
patent: 6207822 (2001-03-01), Thiruvengadam et al.
patent: RE37721 (2002-05-01), Rosenblum et al.
patent: 6426198 (2002-07-01), Cartsea et al.
patent: 6593078 (2003-07-01), Altmann et al.
patent: 6627757 (2003-09-01), Fu et al.
patent: 6632933 (2003-10-01), Altmann et al.
patent: 2002/0151536 (2002-10-01), Davies et al.
patent: 2004/0093629 (2004-05-01), Altmann et al.
patent: 2004/0132058 (2004-07-01), Altmann et al.
patent: 2004/0137467 (2004-07-01), Altmann et al.
patent: WO 00/20623 (2000-04-01), None
patent: WO 00/34240 (2000-06-01), None
patent: WO 00/60107 (2000-10-01), None
patent: WO 00/63703 (2000-10-01), None
patent: WO 01/57190 (2001-08-01), None
patent: WO 01/70974 (2001-09-01), None
patent: WO 01/75067 (2001-10-01), None
patent: WO 02/079174 (2002-10-01), None
patent: WO 03/100094 (2003-12-01), None
patent: WO2004/014947 (2004-02-01), None
patent: WO 2004/32716 (2004-04-01), None
patent: WO2005/69900 (2005-08-01), None
patent: WO2006015365(A1) (2006-02-01), None
Blom et al. (2003) Defective endocytic trafficking of NPC1 and NPC2 underlying infantile Niemann-Pick type C disease. Hum. Mol. Genet., vol. 12, No. 3, pp. 257-272.
Erickson et al., “Studies on neuronal death in the mouse model of Niemann-Pick C disease.” J. Neurosci. Res. Jun. 15, 2002;68(6):738-44.
Erickson et al., “mdr1a deficiency corrects sterility in Niemann-Pick C1 protein deficient female mice.” Mol. Reprod. Dev. Jun. 2002;62(2):167-73.
Altmann et al., “Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption.” Science. Feb. 20, 2004;303(5661):1201-4.
Erickson et al., “Pharmacological and genetic modifications of somatic cholesterol do not substantially alter the course of CNS disease in Niemann-Pick C mice.” J. Inherit. Metab. Dis. Feb. 2000;23(1):54-62.
International Search Report for International Application No. PCT/US03/40113.
International Search Report for International Application No. PCT/US03/22467.
MGI web page “gene detail” of the NPC1L1 gene.
Altmann et al., “Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption.” Science. Feb. 20, 2004;303(5661):1201-4.
Davies et al., Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia. J. Biol. Chem. Apr. 1, 2005;280(13):12710-20.
Minhas, Current Progress in Lipid Therapy Br. J. Cardiology 10(1): 59-68 (2003).
Abstracts 1-79 from “The International Conference on Niemann-Pick Type C Disease”; May 29-31, 2003; Tuscon, Arizona.
Carstea et al., Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis Science 277:228-231 (1997).
Polypeptide Sequence ABG22693 disclosed in WO 01/75067.
Genbank Sequence Disclosure; Accession No. AF192522.
Genbank Sequence Disclosure; Accession No. AF002020.
Davies et al., Evidence for a Niemann-pick C (NPC) gene family: identification and characterization of NPC1L1 Genomics 65(2): 137-145 (2000).
Ioannou et al., “The structure and function of the Niemann-Pick C1 protein.” Mol. Genet. Metab. 71(1-2): 175-181 (2000).
Genbank Sequence Disclosure, Accession No. AK078947.
Altmann et al., “The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption.” Biochim. Biophys. ACTA 1580: 77-93 (2002).
DeNinno et al., “Steroidal glycoside cholesterol absorption inhibitors” J. Med. Chem. 40(16):2547-2554 (1997).
Kramer, et al., “Characterization and identification of the intestinal cholesterol uptake system” Falk Symposium 129, Bile Acids: From Genomics to Disease and Therapy, 147-160 (2003).
Amigo et al., “Relevance of Niemann-Pick Type C1 Protein Expression in Controlling Plasma Cholesterol and Biliary Lipid Secretion in Mice” Hepatology 36(4): 819-828 (2002).
Repa, et al., “Inhibition of cholesterol absorption by SCH 58053 in the mouse is not mediated via changes in the expression of mRNA for ABCA1, ABCG5, or ABCG8 in the enterocyte”. Journal of Lipid Research 43:1864-1874 (2002).
Hauser et al., “Identification of a Receptor Mediating Absorption of Dietary Cholesterol in the Intestine” Biochemistry 37(51): 17843-17850 (1998).
Acton et al., “Expression Cloning of SR-BI, a CD36-related Class B Scavenger Receptor” The Journal of Biological Chemistry 269(33): 21003-21009 (1994).
Hernandez et al., “Intestinal absorption of cholesterol is mediated by a saturable, inhibitable transporter” Biochimica et Biophysica Acta 1486: 232-242 (2000).
Detmers et al., “A target for cholesterol absorption inhibitors in the enterocyte brush border membrane” Biochimica et Biophysica Acta 1486: 243-252 (2000).
Smart et al., “Annexin 2-caveolin 1 complex is a target of ezetimibe and regulates intestinal cholesterol transport” Proc. Natl. Acad. Sci. 101(10):3450-3455 (2004).
Dawson et al., “Intestinal cholesterol absorption” Curr Opin Lipidol. 10(4):315-320 (1999).
Allayee et al., “Biochemistry. An absorbing study of cholesterol” Biochemistry. An absorbing study of cholesterol. Science. 290(5497):1709-1711 (2000).
Berge et al., “Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters” Science 290(5497):1771-1775 (2000).
Jourdheuil-Rahmani et al., “Biliary anionic peptide fraction and apoA-I regulate intestinal cholesterol uptake” Biochem Biophys Res Commun 292(2):390-5 (2002).
Werder et al., “Role of scavenger receptors SR-BI and CD36 in selective sterol uptake in the small intestine” Biochemistry 40(38):11643-50 (2001).
Zetia™ Prescribing Information Sheet.
Ioannou, Multidrug permeases and subcellular cholesterol transport, Nat Rev Mol Cell Biol. Sep. 2001;2(9):657-68.
Altmann Scott W.
Graziano Michael P.
Murgolo Nicholas J.
Wang Luquan
Carlson Karen Cochrane
Liu Samuel Wei
Schering Corporation
LandOfFree
NPC1L1 (NPC3) and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NPC1L1 (NPC3) and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NPC1L1 (NPC3) and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3641256